Brawn Biotech Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 164.95 million compared to INR 222.31 million a year ago. Revenue was INR 165.83 million compared to INR 222.4 million a year ago.

Net loss was INR 15.44 million compared to INR 8.68 million a year ago. Basic loss per share from continuing operations was INR 5.14 compared to INR 3.04 a year ago. Diluted loss per share from continuing operations was INR 5.14 compared to INR 3.04 a year ago.